Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-08 | New | $2,500,000 | $2,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Karl Beutner | Director, Executive |
| Max Dawson | Executive |
| Nichola Eliovits | Director, Executive |
| Daniel Yadegar | Director |